Solicitor general urges Supreme Court to review ‘skinny labeling’ and generic drug access The case is ‘existential for the generics market,’ said one legal expert

https://www.statnews.com/pharmalot/2025/12/09/patents-pharma-generics-scotus-skinny-labels-medicines/